Ambo, Clarkneil M.
HRN: 23-08-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/26/2023
06/02/2023
IV
600mg
Q8H
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes